Two Purchases for January 2016 (Amgen and 3M)
During the month, I made another purchase of Amgen (AMGN). It seemed to be a good time to buy and it starts me on the way to expanding the number of holdings in the healthcare sector. I discuss my original September purchase in this article, and my January purchase was made for the same basic reasons, though at a slightly higher price.
On 01/11/16, I purchased AMGN at $144.50 and 2.77% yield. AMGN was brought up to 2.79% NAV weight and 1.89% dividend weight. I want to cap this stock’s allocation at about 3%, so I don’t have room to add much more. Should the price drop significantly, I will consider one more purchase. Continue reading →